Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04628663

Effects of Dexmedetomidine on Intraocular Pressure During Scheduled Spine Surgeries

The aim of this study is to examine the effects of intraoperative systemic use of dexmedetomidine on the intraocular pressure (IOP) in patients undergoing spine surgeries in a prone position under general anesthesia.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

2nd Department of Anesthesiology, Attikon University Hospital

Athens, Attica, 12462, Greece

Location status: Recruiting

Location contact

Paraskevi Matsota, MD, PhD

CONTACT

[email protected]

+30210583100

About this study

The study is a Prospective, Randomized, Placebo -controlled, Double-Blinded clinical trial Adult patients with an ASA physical status of class I, II or III who are scheduled for an elective spine surgery in prone position under general anesthesia will be included in the study.

The patients will be randomized with closed envelope manner into two groups: the group of dexmedetomidine and the group of normal saline.

In the dexmedetomidine group (DEX group), bolus dose 1,0 μg/kg of dexmedetomidine will be administered in 10min before induction to anesthesia and 0,4-0,8 μg/kg/h of dexmedetomidine will be infused continuously until the end of the surgery.

In the saline group (placebo group), the same volume of saline will be administered in an identical way.

All study medication will be prepared by an independent anesthesiologist who is not associated in the study (who will hold the randomization codes until the end of the study).

All patients will receive the same type of anaesthesia (TIVA with propofol) and postoperative analgesia including paracetamol 1gr iv (4 times/day) and continuous wound infiltration with ropivacaine 0.2% 5ml/h for 48 postoperative hours.

Basic monitoring for the study includes:

ECG, Invasive and noninvasive blood pressure, Heart Rate, EtCO2, SpO2, Cardiac Output (CO), Stroke Volume (SV), Stroke Volume Variation (SVV), Patient State index (PSi), IOP, Urine output.

Measurements

The measurement of IOP will be conducted in both eyes with Icare PRO tonometer by an ophthalmologist who will not know in which group the patient is in the below predefined time points:

  • T1: before administration of the study drug
  • T2: after administration of the bolus dose of the study drug
  • T3: after tracheal intubation
  • T4: just before prone position
  • T5: just after prone position
  • T6: 30min after T5
  • T7: 60min after T6
  • T8: 120min after T7
  • T9: 180min after T8
  • T10: at the end of the surgery and the patient in supine position At the time of each tonometer reading the following data set is collected: MAP, heart rate, EtCO2, SpO2, CO, SV, SVV, urine output, Psi, IOP. Moreover OPP will be calculated as MAP minus IOP.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients undergoing scheduled spine surgery performed in prone position under general anaesthesia

Exclusion criteria

  • Patients who refuse to be a part of the study
  • Patients with previous eye surgery
  • Preexisting eye disease (e.g glaucoma)
  • Allergy to the study drug or any drug which is in the trial
  • Preoperative unstable hemodynamics

Treatment and study plan

Dexmedetomidine

Drug

Administration

Other names: Dexmed

Normal Saline

Other

Administration

Other names: Saline

Primary outcomes

  1. Intraocular pressure (IOP)

    Time frame: Up to 15 minutes after the end of operation

    The measurement of IOP will be conducted in both eyes with Icare PRO tonometer by an ophthalmologist at predefined time points

Study contacts

Contact information is provided by the study sponsor or research team.

Paraskevi Matsota, Prof

CONTACT

[email protected]

6945544563

Sponsors and collaborators

Lead sponsor

Attikon Hospital

Other

Registry information

Official study title

Effects of Systemic Administration of Dexmedetomidine on Intraocular Pressure During Scheduled Spine Surgeries in a Prone Position. Prospective, Randomized, Double-blinded Study.

Important dates

Study start
2021
Primary completion
2025
Study completion
2026
First posted
Nov 13, 2020
Registry last updated
Sep 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.